Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux…
NCT00237068 · Emory University, Other · Unknown status
Key facts
| NCT number | NCT00237068 |
|---|---|
| Title | A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy ( Lansoprazole; Solutab) in the Management of Childhood Asthma |
| Lead sponsor | Emory University, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Lansoprazole, Solutab |
| Enrollment | 100 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Oct 12, 2005 |
| Last update posted | Mar 16, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: